To kick off the US Food and Drug Administration’s 17 October town hall at the Medtech Conference in Toronto, Michelle Tarver addressed industry for the first time as acting director of the Center for Devices and Radiological Health (CDRH). Tarver became acting director in July after Jeff Shuren announced he was stepping away from the post, which he has held for 15 years.
Passing The Torch: Tarver Addresses Audience At FDA Town Hall, Recognizes Shuren’s Accomplishments
In her inaugural address to the medtech industry during the Medtech Conference, acting US CDRH director Michelle Tarver described her mission-driven approach.
More from Medtech Insight
• By
Amendment brings new benefits for device accessories and aesthetic devices used by healthcare professionals.
• By
Leaders of robotic systems companies Distalmotion, Neocis and Noah Medical discussed success metrics, competition and funding. Institutional investors are focusing on utilization, procedure rates and a clear path to profitability as the IPO window reopens, BTIG analyst Ryan Zimmerman said.
• By
The US FDA has issued an early alert to notify consumers about serious risks associated with a recall from Medtronic and its subsidiary Given Imaging. The alert concerns delivery capsules for diagnosing GERD.
• By
The DOJ has launched nearly 70 enforcement actions in 2025, targeting diagnostics, durable medical equipment, and telehealth fraud. Key cases involve significant fraudulent claims against Medicare, with individuals facing severe penalties.
More from Policy & Regulation
• By
After multiple warning letters and safety communications, the US FDA has decided to block the import of certain endoscopes from Olympus. In total, the agency’s action pertains to 58 device models manufactured by the Japanese firm used in urinary, respiratory, abdominal and pelvic procedures.
• By
Healthcare product industries await publication of the NHS 10-Year Plan, due out the coming days, which will focus on health generally not just the NHS, UK health secretary Wes Streeting said during a final prelaunch event on 24 June.
• By
From June 30, new European Commission rules will attempt to redress an imbalance in medtech trade between the EU and the People’s Republic of China.